Orforglipron Pill Shows Promise in Weight Maintenance

Eli Lillys experimental obesity pill, orforglipron, shows promise in maintaining weight loss after stopping injectable treatments. The pill, which is easier to take and more affordable, could be a game-changer for weight management. Lilly has requested FDA approval for the pill as a starting treatment and maintenance therapy.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.